IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Enzon Pharmaceuticals Inc (ENZNEUR)

CUSIP: 293904108 | X1 | 136 institutional holders

Quarters

Q2 2019Q1 2019Q4 2018Q3 2018Q2 2018
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/AIcahn Carl C13,426,45193.7%−22,630,185Mar 25, 20265,904,863 sh (Mar 31, 2016)
13D/AIcahn Carl C13,426,451
93.7% of class · Mar 25, 2026−22,630,185
5,904,863 sh (Mar 31, 2016)

Institutional Holders — Q2 2019

Panagora Asset Management Inc49,119
0.0% of portfolio›$13
StyleTurnoverLocationFiled
Panagora Asset Management Inc
49,119$130.0%CoreMediumBoston, MA2019-08-09